Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;19(12):5642-5662.
doi: 10.1002/alz.13136. Epub 2023 Jun 14.

Early β-amyloid accumulation in the brain is associated with peripheral T cell alterations

Christoph Gericke  1 , Tunahan Kirabali  1 , Roman Flury  2 , Anna Mallone  1   3 , Chiara Rickenbach  1 , Luka Kulic  1   4 , Vinko Tosevski  5 , Christoph Hock  1   6   7 , Roger M Nitsch  1   7 , Valerie Treyer  1   6   8 , Maria Teresa Ferretti  1   9 , Anton Gietl  1   6   10
Affiliations

Early β-amyloid accumulation in the brain is associated with peripheral T cell alterations

Christoph Gericke et al. Alzheimers Dement. 2023 Dec.

Abstract

Introduction: Fast and minimally invasive approaches for early diagnosis of Alzheimer's disease (AD) are highly anticipated. Evidence of adaptive immune cells responding to cerebral β-amyloidosis has raised the question of whether immune markers could be used as proxies for β-amyloid accumulation in the brain.

Methods: Here, we apply multidimensional mass-cytometry combined with unbiased machine-learning techniques to immunophenotype peripheral blood mononuclear cells from a total of 251 participants in cross-sectional and longitudinal studies.

Results: We show that increases in antigen-experienced adaptive immune cells in the blood, particularly CD45RA-reactivated T effector memory (TEMRA) cells, are associated with early accumulation of brain β-amyloid and with changes in plasma AD biomarkers in still cognitively healthy subjects.

Discussion: Our results suggest that preclinical AD pathology is linked to systemic alterations of the adaptive immune system. These immunophenotype changes may help identify and develop novel diagnostic tools for early AD assessment and better understand clinical outcomes.

Keywords: AD plasma biomarkers; Alzheimer's disease; CyTOF; T cells; TEMRA cells; adaptive immune cells; immunophenotyping; phospho-tau; β-amyloid.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535-562.
    1. Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357-367.
    1. Donohue MC, Sperling RA, Petersen R, et al. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA. 2017;317(22):2305-2316.
    1. Ossenkoppele R, Pichet Binette A, Groot C, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28(11):2381-2387.
    1. Bateman RJ, Blennow K, Doody R, et al. Plasma biomarkers of AD emerging as essential tools for drug development: an EU/US CTAD Task Force Report. J Prev Alzheimers Dis. 2019;6(3):169-173.

Publication types

LinkOut - more resources